Two-Dimensional LC/MS/MS to Reduce Ion Suppression in the Determination of Cannabinoids in Blood Plasma

Importance of the topic

Accurate quantification of cannabinoids in blood plasma is essential in forensic toxicology for determining recent cannabis use in cases such as driving under the influence and workplace screening. Complex plasma matrices often cause ion suppression in LC/MS/MS, leading to signal loss, reduced sensitivity, and time consuming sample cleanup. Implementing robust chromatographic strategies to overcome matrix effects enhances analytical reliability and throughput.

Objectives and Study Overview

This study aimed to develop a streamlined method for simultaneous analysis of the psychoactive cannabinoid THC and its metabolites THC COOH and THC OH in plasma using minimal sample pretreatment. The key goal was to overcome matrix-related ion suppression by integrating a two-dimensional LC/MS/MS approach with high resolution heart-cut sampling.

Methodology and Instrumentation

Sample Preparation

• Simple protein precipitation: 100 μL plasma mixed with 100 μL acetonitrile containing formic acid and deuterated internal standards
• Vortex mixing, centrifugation, and direct injection without extensive cleanup

Chromatographic Workflow

• First dimension: C18 RRHD column with gradient elution to separate major components and perform timed heart cuts at retention windows for THC COOH, THC OH, and THC
• Heart-cutting: Multiple small fractions transferred online to the second dimension
• Second dimension: Phenyl-hexyl RRHT column with orthogonal selectivity and fast gradient to resolve analytes from coeluting interferences

Mass Spectrometry

• Agilent Jet Stream electrospray source operated in positive or negative mode as suited to each analyte
• Multiple reaction monitoring transitions optimized for THC, THC COOH, and THC OH and their deuterated analogues

Used instrumentation

• Agilent 1290 Infinity II 2D-LC system with high speed pumps, multisampler, multicolumn thermostat, valve drives and multiple heart-cut valves
• Agilent 6495 Triple Quadrupole LC/MS with Jet Stream technology
• Agilent OpenLab CDS ChemStation and 2D-LC acquisition software; Agilent MassHunter for MS control

Main Results and Discussion

One-dimensional LC/MS/MS showed significant suppression: up to 100 percent loss of THC signal and 58 to 74 percent suppression of THC OH on longer columns. Extending column length improved resolution but did not recover THC quantitation. Two-dimensional LC with high resolution heart-cut sampling restored detectable THC signal, separated interferences, and reduced suppression for THC OH and THC COOH. Calibration was linear from 0.1 to 50 ng/mL (R2 > 0.99), with limits of detection below 0.1 ng/mL and peak area precision under 8 percent.

Benefits and Practical Applications

• Minimal sample cleanup reduces analysis time and solvent use
• Two-dimensional LC heart-cutting effectively mitigates ion suppression from plasma matrix
• Simultaneous quantification of THC and key metabolites in a single run enhances laboratory throughput
• Method meets forensic and clinical requirements for sensitivity, precision and accuracy

Future Trends and Applications

Emerging directions include integration of ultrafast chromatography and high resolution mass spectrometry, application to broader classes of lipophilic drugs and metabolites, and coupling with microfluidic sample handling for fully automated workflows. Advances in stationary phase chemistries and AI-driven method development will further improve suppression control and analytical efficiency.

Conclusion

The described 2D-LC/MS/MS approach successfully overcomes plasma matrix ion suppression, enabling reliable, sensitive and precise quantification of THC and its metabolites with minimal preparation. This strategy offers a powerful tool for forensic and clinical laboratories analyzing challenging biological matrices.

References

• Hádener M et al. Anal Bioanal Chem 2016 408 1953 1962
• Desrosiers N et al. J Anal Toxicol 2015 39 251 261
• Crifasi J Honnold R Kubas R. Agilent Technologies Application Note 5991-1609EN 2012
• Van Damme E et al. Anal Bioanal Chem 2014 406 401 407